Are trough tobramycin concentrations taken from a central venous catheter accurate enough to safely use?

Arch Dis Child. 2022 May;107(5):512-514. doi: 10.1136/archdischild-2022-323836. Epub 2022 Feb 24.

Authors

Hannah Tumelty¹, Geoff Shenton², Malcolm Brodlie^{3

4}

Affiliations

¹ General Paediatrics, Great North Children's Hospital, Newcastle upon Tyne, UK hannah.tumelty@nhs.net.
² Paediatric Oncology and Haematology, Great North Children's Hospital, Newcastle upon Tyne, UK.
³ Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
⁴ Paediatric Respiratory Medicine, Great North Children's Hospital, Newcastle Upon Tyne, UK.

PMID: 35210219
DOI: 10.1136/archdischild-2022-323836

No abstract available

Keywords: cystic fibrosis; paediatrics.

MeSH terms

Anti-Bacterial Agents / therapeutic use
Central Venous Catheters* / adverse effects
Cystic Fibrosis* / drug therapy
Humans
Pseudomonas Infections* / drug therapy
Tobramycin

Substances

Anti-Bacterial Agents
Tobramycin